Citations 1
Significant overall survival improvement in proliferative subtype ovarian cancer patients receiving bevacizumab.
Kommoss, Stefan , Winterhoff, Boris , Wang, Chen , Aliferis, Constantin , Kimmig, Rainer , Wang, Jinhua , Ma, Sisi , Gregorio, Nikolaus de , Mahner, Sven� , Tourani, Roshan , Park‐Simon, Tjoung‐Won , Baumann, Klaus , Taran, Florin‐Andrei , Kommoss, Friedrich, Schroeder, W., Dowdy, Sean C. , Pfisterer, Jacobus , Heitz, Florian , Sehouli, Jalid , Ma, Sisi , Bois, Andreas du
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5520-5520
